Association between self-reported alcohol consumption and diastolic dysfunction: a cross-sectional study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
11 10 2023
Historique:
medline: 23 10 2023
pubmed: 12 10 2023
entrez: 11 10 2023
Statut: epublish

Résumé

While alcohol consumption is associated with common risk factors for diastolic dysfunction the independent impact of low levels of alcohol consumption on this condition in a community setting is still unclear.Thus, the aim of this study was to explore this association in a representative population sample employing optimal echocardiographic techniques. Cross-sectional observational study in community-based population. Participants between 30 and 75 years of age were consecutively invited to a physical examination, interview, conventional echocardiography, including Tissue Velocity Imaging. Diastolic dysfunction was defined according to the European Society of Cardiology criteria, excluding subjects with ejection fraction <45%, self-reported history of heart failure or atrial fibrillation on ECG. Self-reported alcohol intake using a validated questionnaire was categorised as In total, 500 men and 538 women (mean age 55.4±13) were successfully examined. Diastolic dysfunction was identified in 16% (79/500) of the men and 13% (58/538) of the women. The multivariable adjusted model revealed a strong and independent association between alcohol intake and diastolic dysfunction. In fact, using no alcohol intake as reference, diastolic dysfunction was independently associated with alcohol consumption in a dose-dependent fashion; There was a significant association between alcohol consumption and diastolic dysfunction starting already at low levels that was supported by a dose-dependent pattern. These results need confirmatory studies and are important in public health policies.

Sections du résumé

BACKGROUND AND OBJECTIVES
While alcohol consumption is associated with common risk factors for diastolic dysfunction the independent impact of low levels of alcohol consumption on this condition in a community setting is still unclear.Thus, the aim of this study was to explore this association in a representative population sample employing optimal echocardiographic techniques.
DESIGN
Cross-sectional observational study in community-based population.
SETTINGS, PARTICIPANTS AND METHODS
Participants between 30 and 75 years of age were consecutively invited to a physical examination, interview, conventional echocardiography, including Tissue Velocity Imaging. Diastolic dysfunction was defined according to the European Society of Cardiology criteria, excluding subjects with ejection fraction <45%, self-reported history of heart failure or atrial fibrillation on ECG. Self-reported alcohol intake using a validated questionnaire was categorised as
RESULTS
In total, 500 men and 538 women (mean age 55.4±13) were successfully examined. Diastolic dysfunction was identified in 16% (79/500) of the men and 13% (58/538) of the women. The multivariable adjusted model revealed a strong and independent association between alcohol intake and diastolic dysfunction. In fact, using no alcohol intake as reference, diastolic dysfunction was independently associated with alcohol consumption in a dose-dependent fashion;
CONCLUSION
There was a significant association between alcohol consumption and diastolic dysfunction starting already at low levels that was supported by a dose-dependent pattern. These results need confirmatory studies and are important in public health policies.

Identifiants

pubmed: 37821143
pii: bmjopen-2022-069937
doi: 10.1136/bmjopen-2022-069937
pmc: PMC10583109
doi:

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e069937

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Am J Epidemiol. 2002 Feb 1;155(3):242-8
pubmed: 11821249
Alcohol. 2007 Sep;41(6):399-402
pubmed: 17936508
Cardiovasc Res. 1983 Feb;17(2):81-7
pubmed: 6223697
Eur Heart J. 2005 Jun;26(11):1115-40
pubmed: 15901669
JAMA. 2003 Jan 8;289(2):194-202
pubmed: 12517230
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
Ann Intern Med. 2002 Feb 5;136(3):181-91
pubmed: 11827493
Biol Res. 2004;37(2):253-61
pubmed: 15455655
Hypertension. 2016 Nov;68(5):1208-1216
pubmed: 27672023
Nat Rev Cardiol. 2015 Oct;12(10):576-87
pubmed: 26099843
J Epidemiol Community Health. 2000 May;54(5):328-32
pubmed: 10814651
Addiction. 2018 Dec;113(12):2245-2249
pubmed: 30014539
Ann Gastroenterol. 2014;27(3):250-257
pubmed: 24974978
Diabetes Res Clin Pract. 2007 Nov;78(2):217-24
pubmed: 17448561
Metabolism. 2012 Apr;61(4):590-8
pubmed: 22146090
Int J Obes (Lond). 2008 Mar;32(3):533-40
pubmed: 18209739
Cardiovasc Toxicol. 2014 Dec;14(4):291-308
pubmed: 24671642
Ther Adv Cardiovasc Dis. 2008 Dec;2(6):497-506
pubmed: 19124444
Clin Nutr. 2018 Aug;37(4):1247-1251
pubmed: 28554815
J Am Soc Echocardiogr. 1997 Apr;10(3):246-70
pubmed: 9109691
Am J Cardiol. 1990 Dec 15;66(20):1473-7
pubmed: 2251994
Eur J Heart Fail. 2000 Jun;2(2):151-60
pubmed: 10856728
Eur Heart J Cardiovasc Imaging. 2018 Mar 1;19(3):271-278
pubmed: 28459993
Herz. 2006 Jun;31(4):305-16
pubmed: 16810470
BMJ Open. 2018 May 3;8(5):e020777
pubmed: 29724742
Alcohol Alcohol. 2000 Mar-Apr;35(2):134-8
pubmed: 10787387
Front Public Health. 2022 May 04;10:859947
pubmed: 35602135
J Mol Cell Cardiol. 1998 Nov;30(11):2487-94
pubmed: 9925383
J Stud Alcohol. 1994 Nov;55(6):695-700
pubmed: 7861798
J Am Coll Cardiol. 2000 May;35(6):1599-606
pubmed: 10807466
Diabetes Care. 2006 Sep;29(9):2140-57
pubmed: 16936169
Int J Cardiol. 2005 May 25;101(2):209-12
pubmed: 15882665
N Engl J Med. 1989 Feb 16;320(7):409-15
pubmed: 2913506
Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):98-104
pubmed: 18674890
Circulation. 2007 Jan 2;115(1):34-9
pubmed: 17130341
J Hypertens. 1999 Feb;17(2):151-83
pubmed: 10067786
Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1249-1259
pubmed: 32446870
Eur Heart J. 2003 Feb;24(4):320-8
pubmed: 12581679
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
BMC Cardiovasc Disord. 2008 Dec 11;8:37
pubmed: 19077249
Circ Heart Fail. 2012 Mar 1;5(2):144-51
pubmed: 22278404
Alcohol. 2007 Nov;41(7):479-88
pubmed: 17980786
Eur Heart J. 1998 Jul;19(7):990-1003
pubmed: 9717033

Auteurs

Bledar Daka (B)

Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden bledar.daka@allmed.gu.se.

Louise Bennet (L)

Family Medicine, Deaprtment of Clinical Sciences, Lund University, Malmo, Sweden.

Lennart Råstam (L)

Family Medicine, Deaprtment of Clinical Sciences, Lund University, Malmo, Sweden.

Margareta I Hellgren (MI)

Medicine, University of Gothenburg, Göteborg, Sweden.

Ying Li (Y)

Medicine, Sahlgrenska Akademy, Goteborg, Sweden.

Martin Magnusson (M)

Lund University, Lund, Sweden.

Ulf Lindblad (U)

Family Medicine, Deaprtment of Clinical Sciences, Lund University, Malmo, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH